The clinicopathological evaluation of the breast cancer patients with brain metastases: predictors of survival

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Clinical and Experimental Metastasis

• Publication date

  2012-08-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10585-012-9528-7PMID 22915160
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Incidence of brain metastases as a first site of recurrence among women with triple receptor–negative breast cancer

  2012cited by this paper
• Brain metastases free survival differs between breast cancer subtypes

  2012cited by this paper
• Cancer Statistics, 2011: The Impact of Eliminating Socioeconomic and Racial Disparities on Premature Cancer Deaths

  2012cited by this paper
• Central Nervous System Metastases in Patients with HER2-Positive Metastatic Breast Cancer: Incidence, Treatment, and Survival in Patients from registHER

  2011cited by this paper
• Cancer statistics, 2011

  2011cited by this paper
• The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases

  2011cited by this paper
• Clinical outcome of central nervous system metastases from breast cancer: differences in survival depending on systemic treatment

  2011cited by this paper
• Triple-negative breast cancer with brain metastases: a comparison between basal-like and non-basal-like biological subtypes

  2011cited by this paper
• Incidence of brain metastases as a first site of recurrence among women with triple receptor-negative breast cancer.

  2011cited by this paper
• Ajcc Cancer Staging Manual. 7th Ed. New

  2010cited by this paper
• Patterns of relapse and metastatic spread in HER2-overexpressing breast cancer according to estrogen receptor status

  2010cited by this paper
• Patterns of relapse in breast cancer: changes over time

  2010cited by this paper
• Clinical Outcomes and Breast Cancer Subtypes in Patients with Brain Metastases

  2010cited by this paper
• Breast cancer brain metastases: differences in survival depending on biological subtype, RPA RTOG prognostic class and systemic treatment after whole-brain radiotherapy (WBRT).

  2010cited by this paper
• Triple-negative and HER2-overexpressing breast cancers exhibit an elevated risk and an earlier occurrence of cerebral metastases.

  2009cited by this paper
• Survival among women with triple receptor-negative breast cancer and brain metastases.

  2009cited by this paper
• Trastuzumab treatment improves brain metastasis outcomes through control and durable prolongation of systemic extracranial disease in HER2-overexpressing breast cancer patients

  2009cited by this paper
• Characteristics of breast cancer patients with central nervous system metastases: a single-center experience.

  2008cited by this paper
• Sites of distant recurrence and clinical outcomes in patients with metastatic triple‐negative breast cancer

  2008cited by this paper
• The role of hormonal therapy in the management of hormonal-receptor-positive breast cancer with co-expression of HER2

  2008cited by this paper
• Subtypes of breast cancer show preferential site of relapse.

  2008cited by this paper
• Brain metastases in breast cancer: prognostic factors and management

  2008cited by this paper
• Survival in patients with brain metastases from breast cancer

  2008cited by this paper
• Central nervous system metastases in HER-2-overexpressing metastatic breast cancer: a treatment challenge.

  2008cited by this paper
• Central nervous system metastases in HER-2 positive metastatic breast cancer patients treated with trastuzumab: incidence, survival, and risk factors.

  2007cited by this paper
• Brain Metastases: The HER2 Paradigm

  2007cited by this paper
• Trastuzumab treatment and the risk of central nervous system (CNS) metastases

  2007cited by this paper
• Genes associated with breast cancer metastatic to bone.

  2006cited by this paper
• Primary breast cancer phenotypes associated with propensity for central nervous system metastases

  2006cited by this paper
• Incidence, pattern and timing of brain metastases among patients with advanced breast cancer treated with trastuzumab

  2006cited by this paper
• The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells.

  2006cited by this paper
• Characteristics of patients with brain metastases receiving trastuzumab for HER2 overexpressing metastatic breast cancer.

  2006cited by this paper
• Isolated central nervous system metastases in patients with HER2-overexpressing advanced breast cancer treated with first-line trastuzumab-based therapy.

  2005cited by this paper
• Increased risk of brain metastases in patients with HER‐2/neu‐positive breast carcinoma

  2005cited by this paper
• Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System.

  2004cited by this paper
• HER-2/neu Gene and protein in breast cancer

  2004cited by this paper
• Repeated observation of breast tumor subtypes in independent gene expression data sets

  2003cited by this paper
• The Her-2/neu gene and protein in breast cancer 2003: biomarker and target of therapy.

  2003cited by this paper
• A multigenic program mediating breast cancer metastasis to bone.

  2003cited by this paper
• Prognostic factors in breast cancer

  2002cited by this paper
• Expert Commentary.

  2002cited by this paper
• Molecular portraits of human breast tumours

  2000cited by this paper
• Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999.

  2000cited by this paper
• Brain metastases in breast cancer: prognostic factors and management.

  1999cited by this paper
• Pathological prognostic factors in breast cancer.

  1999cited by this paper
• Central nervous system metastasis in breast cancer.

  1996cited by this paper
• pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐up

  1991cited by this paper
• Central nervous system metastasis from breast carcinoma autopsy study

  1983cited by this paper
• Toxicity and response criteria of the Eastern Cooperative Oncology Group

  1982cited by this paper

• Surgical treatment of multiple breast cancer brain metastases: clinical characteristics and factors impacting postoperative survival

  2025cites this paper
• Breast Cancer Patients with Brain Metastases: A Cross-Sectional Study

  2022cites this paper
• Prediction of Short and Long Survival after Surgery for Breast Cancer Brain Metastases

  2022cites this paper
• Risk factors for breast cancer brain metastases: a systematic review

  2020influential citation
• HER2-targeted therapy prolongs survival in patients with HER2-positive breast cancer and intracranial metastatic disease: a systematic review and meta-analysis

  2020cites this paper
• Identification of ALDH1A3 as a Viable Therapeutic Target in Breast Cancer Metastasis–Initiating Cells

  2020cites this paper
• Treatment Patterns and Survival of Elderly Patients With Breast Cancer Brain Metastases

  2019cites this paper
• Metastatic Breast Cancer Survival in Pointe Noire: Analysis of 30 Cases

  2019cites this paper
• Applying Cox proportional hazards model to identifying the factors affecting the survival of patients with brain metastases

  2017cites this paper
• Prognostic factors and survival according to tumour subtype in women presenting with breast cancer brain metastases at initial diagnosis.

  2017cites this paper
• Brain Metastases in Newly Diagnosed Breast Cancer: A Population-Based Study

  2017cites this paper
• A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer

  2016cites this paper
• Quantitative extracellular matrix proteomics to study mammary and liver tissue microenvironments.

  2016cites this paper
• Brain metastasis in breast cancer: a comprehensive literature review

  2016cites this paper
• uantitative extracellular matrix proteomics to study mammary and iver tissue microenvironments rica

  2016cites this paper
• Population-based Analysis of Treatment and Survival in Women Presenting With Brain Metastasis at Initial Breast Cancer Diagnosis

  2016cites this paper
• Prognostic factors and survival of patients with brain metastasis from breast cancer who underwent craniotomy

  2015cites this paper
• Clinicopathological Evaluation and Prognostic Analysis in Breast Cancer Patients with Brain Metastasis

  2015cites this paper
• Early versus Delayed Therapy of Advanced Gastric Cancer Patients - Does It Make a Difference?

  2015cites this paper
• Treatment and prognosis of breast cancer patients with brain metastases according to intrinsic subtype.

  2014cites this paper
• Analysis of miRNA Expression in Breast Cancer

  2013cites this paper
• Radiotherapy versus best supportive care in patients with brain metastases and adverse prognostic factors

  2013cites this paper
• Biology of brain metastases and novel targeted therapies: time to translate the research.

  2013cites this paper